Dashboard
1
Poor Management Efficiency with a low ROE of 0.95%
- The company has been able to generate a Return on Equity (avg) of 0.95% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Operating profit has grown by an annual rate -199.82% of over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
4
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.21%
0%
-3.21%
6 Months
7.11%
0%
7.11%
1 Year
16.31%
0%
16.31%
2 Years
46.49%
0%
46.49%
3 Years
79.47%
0%
79.47%
4 Years
34.16%
0%
34.16%
5 Years
0.74%
0%
0.74%
Diaceutics Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.07%
EBIT Growth (5y)
-199.82%
EBIT to Interest (avg)
-1.06
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.53
Tax Ratio
10.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.74%
ROE (avg)
0.95%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.76
EV to EBIT
-58.26
EV to EBITDA
45.91
EV to Capital Employed
4.79
EV to Sales
3.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.22%
ROE (Latest)
-4.08%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'22
Dec'22
Dec'21
Change(%)
Net Sales
19.50
13.90
40.29%
Operating Profit (PBDIT) excl Other Income
3.30
2.10
57.14%
Interest
0.10
0.10
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.70
0.60
16.67%
Operating Profit Margin (Excl OI)
17.00%
22.40%
-0.54%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2022 is 40.29% vs 9.45% in Dec 2021
Consolidated Net Profit
YoY Growth in year ended Dec 2022 is 16.67% vs 100.00% in Dec 2021
About Diaceutics Plc 
Diaceutics Plc
Pharmaceuticals & Biotechnology
Diaceutics PLC is a United Kingdom-based data analytics and implementation services company which services the global pharmaceutical industry. The Company offers end to end services that encompasses from understanding the diagnostic landscape to test implementation into treatment pathways to enable better treatment decisions for patients. The Company’s data analytics and implementation services, including Landscape, Tracking, and Primary Market Research, leverages the diagnostic testing information to provide data-driven insights to drive seamless integration of diagnostic tests into treatment pathways. Its implementation services include Planning, Commercialization and Reimbursement Landscapes, to build the strategies and implement the tactics that drives optimal test utilization, ensuring that patients are getting the right treatment.
Company Coordinates 
Company Details
727 Antrim Road , BELFAST NIR : BT2 8FE
Registrar Details






